THRIVE HEALTHCARE LLC – Trademark Portfolio
Entity Type: 16
THRIVE HEALTHCARE LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 10 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include TRIMRX, EXTENDRX, ELEVATERX, STRONGDNA, and UNLOCK THE POWER OF YOUR GENETIC CODE. The owner is based in Austin, TX.
11190 Circle Dr., Suite 490
Austin, TX 78736
Showing of trademarks Trademarks
Trademark Classifications
THRIVE HEALTHCARE LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does THRIVE HEALTHCARE LLC have?
THRIVE HEALTHCARE LLC has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 6 abandoned.
What trademark classes does THRIVE HEALTHCARE LLC file in?
THRIVE HEALTHCARE LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are THRIVE HEALTHCARE LLC's most well-known trademarks?
THRIVE HEALTHCARE LLC's registered trademark portfolio includes well-known marks such as TRIMRX, EXTENDRX, ELEVATERX, STRONGDNA, and UNLOCK THE POWER OF YOUR GENETIC CODE. These are among 6 currently registered trademarks in the portfolio.
What is THRIVE HEALTHCARE LLC's trademark registration success rate?
THRIVE HEALTHCARE LLC has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.